INTUITIVE SURGICAL INC (ISRG) Scores High on Benjamin Graham's Value Investor Model

INTUITIVE SURGICAL INC (ISRG) is a large-cap growth stock in the Medical Equipment & Supplies industry. It rates highest using the Value Investor model based on Benjamin Graham's strategy, scoring 71%. The stock meets Graham's criteria for low P/B and P/E ratios, low debt, and solid long-term earnings growth. However, it fails to meet the criteria for P/E ratio and price/book ratio.

Intuitive Surgical Inc. (ISRG), a leader in the medical equipment and supplies industry, is set to release its quarterly earnings report on July 22, 2025. Analysts anticipate the company to report an earnings per share (EPS) of $1.77. This announcement comes amidst a period of robust growth and strategic advancements for ISRG.

Historically, Intuitive Surgical has demonstrated strong earnings performance. In the previous quarter, the company beat EPS estimates by $0.09, leading to a 1.92% increase in share price. Over the last 52 weeks, shares of ISRG have appreciated by 13.64%, reflecting a generally positive performance [1].

The company has received a high rating of 71% based on Benjamin Graham's value investing strategy. ISRG meets the criteria for low P/B and P/E ratios, low debt, and solid long-term earnings growth. However, it fails to meet the criteria for P/E ratio and price/book ratio [2].

In the first quarter of 2025, ISRG reported strong procedure growth of 17%, with notable strength in general surgery in the United States and regional performance in India, Korea, and the United Kingdom. The company placed 367 da Vinci systems, a 17% increase from the previous year. This expansion in installed base is part of ISRG's strategy to enhance its global dominance in robotic-assisted surgery [2].

Intuitive Surgical recently showcased its cutting-edge telesurgery technology at the Society of Robotic Surgery conference in Strasbourg, France. This innovation allows surgeons to perform remote surgeries, enhancing patient access to minimally invasive procedures. The company's CEO emphasized the necessity for careful technological development to ensure patient safety and added value [3].

Wall Street analysts have forecasted an average target price of $587.27 for ISRG, with a high estimate of $675.00 and a low estimate of $440.00. This implies an upside of 14.65% from the current price of $512.23. The average brokerage recommendation is currently 2.1, indicating an "Outperform" status [3].

Intuitive Surgical's long-term growth will hinge on improving per-system productivity, proving clinical differentiation, and navigating financial headwinds. The company's focus on innovation and strategic market expansion positions it well to capitalize on these opportunities.

References:
[1] https://www.benzinga.com/insights/earnings/25/07/46519911/insights-ahead-intuitive-surgicals-quarterly-earnings
[2] https://www.ainvest.com/news/intuitive-surgical-isrg-benjamin-graham-investor-model-rating-2507/
[3] https://www.gurufocus.com/news/2981443/intuitive-surgical-isrg-showcases-telesurgery-innovation-isrg-stock-news